Features, pricing, ratings, and pros and cons, compared head to head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). Venn Blue Border is a commercial secure enterprise browsers tool by Venn. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack. Independent and vendor-neutral: our scores and rankings are earned, never bought — sponsored placement is always labeled.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Tool that immunizes Windows systems against critical vulnerabilities
Secure workspace for BYOD/unmanaged devices without VDI or device takeover
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs Venn Blue Border for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
Venn Blue Border: Secure workspace for BYOD/unmanaged devices without VDI or device takeover. built by Venn. Core capabilities include Secure Enclave on unmanaged PC and Mac devices, Local application execution without VDI or virtualization, Data encryption and isolation within Blue Border workspace..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Venn Blue Border differentiates with Secure Enclave on unmanaged PC and Mac devices, Local application execution without VDI or virtualization, Data encryption and isolation within Blue Border workspace.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Venn Blue Border is developed by Venn. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
360 High-Risk Vulnerability Immunization Tool V2.0 and Venn Blue Border serve similar Endpoint Protection Platform use cases. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox